INDUCTION OF HETEROTYPIC VIRUS-RESISTANCE IN ADULT INBRED MICE IMMUNIZED WITH A VARIANT OF COXSACKIEVIRUS-B3

被引:11
作者
LANDAU, BJ
WHITTIER, PS
FINKELSTEIN, SD
ALSTEIN, B
GRUN, JB
SCHULTZ, M
CROWELL, RL
机构
[1] HAHNEMANN UNIV,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19102
[2] HAHNEMANN UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19102
关键词
BALB/c mice; C3H/HeJ mice; C57B1/6; mice; C57B1/6-bg[!sup]J[!/sup]/bg[!sup]J[!/sup] mice; Coxsackievirus B1; Coxsackievirus B3; cytokines; heart muscle disease; hepatitis; heterotypic virus resistance; liver regeneration; pancreatitis;
D O I
10.1016/0882-4010(90)90054-T
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection of adult male C3H/HeJ mice with a host range variant of Coxsackievirus B3 (CB3W-RD) induced resistance in these mice to an otherwise lethal dose of Coxsackievirus B1 (CB1). The protective effect induced by CB3W-RD was detectable as early as 1 day post-vaccination and was still present 10 weeks later. While untreated mice infected with CB1 died within 5 days because of massive hepatic necrosis, the liver was spared in mice immunized with CB3W-RD and then challenged with CB1. In general, CB1 titers in heart, liver, and pancreas of CB3W-RD-vaccinated animals were lower than that found in unvaccinated animals. Virus neutralizing antibody was not a mediator of this heterotypic, virus-induced protective effect. In addition, the outcome of CB1 infection could be modified if superinfection with CB3W-RD took place within 1-4 days following CB1 infection. In this regard, maximum therapeutic efficacy was observed when CB1 infected mice were superinfected 2 days after CB1 infection. CB1-infected mice that survived as a result of treatment with CB3W-RD exhibited liver regeneration but did develop myocardial necrosis. © 1990.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 32 条
[1]   FAILURE OF LIVE, ORAL VIRUS-VACCINES IN DEVELOPING-COUNTRIES [J].
ALBERT, MJ .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (06) :1350-1350
[2]   EFFECT OF ANTICELLULAR SERUM ON ATTACHMENT OF ENTEROVIRUSES TO HELA CELLS [J].
AXLER, DA ;
CROWELL, RL .
JOURNAL OF VIROLOGY, 1968, 2 (08) :813-+
[3]   A NEW SUBTYPE OF A NATURAL VIRAL INHIBITOR (CVI) THAT IS STABLE IN THE GASTROINTESTINAL-TRACT [J].
BARON, JL ;
LI, JL ;
MCKERLIE, ML ;
SHABOT, JM ;
COPPENHAVER, DH .
MICROBIAL PATHOGENESIS, 1986, 1 (03) :241-247
[4]   BROADLY ACTIVE INHIBITOR OF VIRUSES SPONTANEOUSLY PRODUCED BY MANY CELL-TYPES IN CULTURE [J].
BARON, S ;
MCKERLIE, L .
INFECTION AND IMMUNITY, 1981, 32 (02) :449-453
[5]   ROLE OF ANTIVIRAL ANTIBODIES IN RESISTANCE AGAINST COXSACKIEVIRUS-B3 INFECTION - INTERACTION BETWEEN PRE-EXISTING ANTIBODIES AND AN INTERFERON INDUCER [J].
CHO, CT ;
FENG, KK ;
MCCARTHY, VP ;
LENAHAN, MF .
INFECTION AND IMMUNITY, 1982, 37 (02) :720-727
[6]   SIZE AND STABILITY OF A NATURALLY-OCCURRING VIRUS INHIBITOR [J].
COPPENHAVER, DH ;
BARON, JL ;
MCKERLIE, ML ;
SABADOS, J ;
BARON, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) :646-649
[7]   MAMMALIAN CELL-VIRUS RELATIONSHIP .6. SUSTAINED INFECTION OF HELA CELLS BY COXSACKIE B3 VIRUS AND EFFECT ON SUPERINFECTION [J].
CROWELL, RL ;
SYVERTON, JT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1961, 113 (02) :419-&
[8]   SPECIFIC ALTERATIONS OF COXSACKIEVIRUS B3 ELUTED FROM HELA CELLS [J].
CROWELL, RL ;
PHILIPSON, L .
JOURNAL OF VIROLOGY, 1971, 8 (04) :509-+
[9]   SPECIFICITY OF IGM ANTIBODIES IN ACUTE HUMAN COXSACKIEVIRUS-B INFECTIONS, ANALYZED BY INDIRECT SOLID-PHASE ENZYME-IMMUNOASSAY AND IMMUNOBLOT TECHNIQUE [J].
DORRIES, R ;
TERMEULEN, V .
JOURNAL OF GENERAL VIROLOGY, 1983, 64 (JAN) :159-167
[10]  
ESTRIN M, 1986, AM J PATHOL, V125, P578